Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Radiotherapy Omission”

31 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 31 results

Not applicableActive Not RecruitingNCT02400190
What this trial is testing

The IDEA Study (Individualized Decisions for Endocrine Therapy Alone)

Who this might be right for
Breast Neoplasms
University of Michigan Rogel Cancer Center 202
Large-scale testing (Phase 3)Looking for participantsNCT07762885
What this trial is testing

Omission of Adjuvant Radiotherapy in Low- and Intermediate-Risk Ductal Carcinoma In Situ After Breast-Conserving Surgery

Who this might be right for
Ductal Carcinoma In Situ, DCIS
Fudan University 636
Testing effectiveness (Phase 2)WithdrawnNCT05371860
What this trial is testing

Radiation Omission in Patients With HER2 Overexpressing Tumors With Pathologic Complete Response

Who this might be right for
Breast CancerHER2-positive Breast Cancer
Armando Giuliano
Large-scale testing (Phase 3)Looking for participantsNCT07528495
What this trial is testing

A Trial Evaluating Omission of Radiotherapy to Regional Lymphatic's

Who this might be right for
Head and Neck Cancer
All India Institute of Medical Sciences 396
Not applicableNot Yet RecruitingNCT07674342
What this trial is testing

Neoadjuvant PD-1 Inhibitor Plus SOX Chemotherapy With or Without Short-Course Radiotherapy for Locally Advanced Upper Gastric or GEJ Adenocarcinoma

Who this might be right for
Locally Advanced Proximal Gastric or Gastroesophageal Junction Adenocarcinoma
Tongji Hospital 146
Not applicableActive Not RecruitingNCT03878342
What this trial is testing

Radiotherapy Omission in Low Risk Ductal in Situ Carcinoma Breast

Who this might be right for
DCISBreast CancerLow Risk DCIS+2 more
UNICANCER 295
Large-scale testing (Phase 3)Looking for participantsNCT05440149
What this trial is testing

The Postoperative Radiotherapy in N1 Breast Cancer Patients

Who this might be right for
RadiotherapyBreast Cancer
Seoul National University Hospital 1,106
Testing effectiveness (Phase 2)Looking for participantsNCT07513389
What this trial is testing

Omission of Postoperative Radiation in HPV-Associated Oropharyngeal Cancer Using ctHPVDNA Surveillance (OPERATION)

Who this might be right for
Squamous Cell CarcinomaHuman Papilloma Virus (HPV)Oropharyngeal Squamous Cell Carcinoma (OPSCC)
Medical University of South Carolina 36
Large-scale testing (Phase 3)Looking for participantsNCT07177443
What this trial is testing

Serplulimab Combined With Induction Chemotherapy and Radiotherapy in Nasopharyngeal Carcinoma

Who this might be right for
Locally Advanced Nasopharyngeal Carcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 710
Not applicableLooking for participantsNCT07829848
What this trial is testing

Response-Adapted Omission of Nodal Boost In N3 Breast Cancer After Neoadjuvant Systemic Therapy

Who this might be right for
Breast Cancer
Fudan University 534
Not applicableActive Not RecruitingNCT03460067
What this trial is testing

Omission of Radiation in Patients With Her-2 Positive Breast Cancer

Who this might be right for
HER2-positive Breast Cancer
University of Kansas Medical Center 12
Testing effectiveness (Phase 2)Looking for participantsNCT06897488
What this trial is testing

EMERALD: Endocrine Therapy oMission With Radiation in ER+ Breast Cancer: Assessing Quality of Life and Disease Control: a Prospective Phase II Trial

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 300
Testing effectiveness (Phase 2)Looking for participantsNCT07755449
What this trial is testing

CLEAR (Cervical Lymphatic Exclusion in Adjuvant Radiation)

Who this might be right for
Locally Advanced Head and Neck Squamous Cell Carcinoma
Institut Català d'Oncologia 101
Testing effectiveness (Phase 2)Looking for participantsNCT06938724
What this trial is testing

Omission of Local Therapies in Women Patients With HER2-positive or Triple-negative Breast Cancer

Who this might be right for
Breast Neoplasm Malignant Female
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 152
Not applicableLooking for participantsNCT05866458
What this trial is testing

Radiation OmisSion in PAtients With CLinically Node Negative Breast Cancer Undergoing Lumpectomy

Who this might be right for
Breast Cancer
Ontario Clinical Oncology Group (OCOG) 352
Testing effectiveness (Phase 2)Looking for participantsNCT07762924
What this trial is testing

Omission of Adjuvant Radiotherapy in Young Low-Risk Ductal Carcinoma In Situ Following Breast-Conserving Surgery

Who this might be right for
Ductal Carcinoma In Situ, DCIS
Fudan University 234
Large-scale testing (Phase 3)Not Yet RecruitingNCT07268690
What this trial is testing

Risk-Adapted Omission of Level Va Irradiation in Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma by AJCC V9 Stage
Fujian Cancer Hospital 474
Testing effectiveness (Phase 2)Looking for participantsNCT06464913
What this trial is testing

Randomized Phase II Trial: Chest Wall RT Omission After Prosthetic Reconstruction

Who this might be right for
Breast Neoplasms
Second Affiliated Hospital, Zhejiang University, School of Medicine 152
Not applicableUnknownNCT05650034
What this trial is testing

Post-Operative Radiotherapy De-Escalation of Negative Nodal Regions in Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Carcinoma
National Cancer Institute, Egypt 57
Testing effectiveness (Phase 2)Active Not RecruitingNCT02653755
What this trial is testing

The PRECISION Trial (Profiling Early Breast Cancer for Radiotherapy Omission): A Phase II Study of Breast-Conserving Surgery Without Adjuvant Radiotherapy for Favorable-Risk Breast Cancer

Who this might be right for
Breast Cancer Radiation
Dana-Farber Cancer Institute 671
Next Page